CCL11 and pancolitis: When categorized by the extent of mucosal disease activity, there was an increase in the serum eotaxin-1 from patients with either left-sided colitis or pancolitis vs. control patients, but this was significantly further increased in patients with pancolitis vs. left-sided colitis, further indicating the potential utility of eotaxin-1 measurement in patient stratification.